You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

centrally located NSCLC

Showing 1 - 25 of 5,307
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Observing Palliative Asymptomatic Centrally Located Advanced

Active, not recruiting
  • Non-small Cell Lung Carcinoma
  • None: Questionnaire Study
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 6, 2022

SBRT, NSCLC, Non-metastatic Trial in United States (GC4711, Placebo)

Recruiting
  • SBRT
  • +2 more
  • Gilbert, Arizona
  • +11 more
Aug 9, 2022

NSCLC Trial in New Haven (45 Gray (Gy) regimen)

Recruiting
  • Non-small Cell Lung Cancer
  • 45 Gray (Gy) regimen
  • New Haven, Connecticut
    Smilow Cancer Hospital
Jul 20, 2022

Centrally Located Hepatocellular Carcinoma, Stereotactic Body Radiotherapy, Hepatectomy Trial in Hangzhou (Neoadjuvant

Not yet recruiting
  • Centrally Located Hepatocellular Carcinoma
  • +2 more
  • Neoadjuvant stereotactic body radiation therapy (Multiple ascending dose) followed by hepatectomy for centrally located hepatocellular carcinoma.
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Oct 27, 2022

Lung Cancer, Metastases to Lung, Radiotherapy Side Effect Trial in Denmark (STRICT LUNG, STAR LUNG)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • STRICT LUNG
  • STAR LUNG
  • Aalborg, Denmark
  • +5 more
Apr 24, 2022

Benign Centrally-Located Intracranial Tumors Trial in Washington, Miami (ExAblate 4000 System)

Recruiting
  • Benign Centrally-Located Intracranial Tumors
  • ExAblate 4000 System
  • Washington, District of Columbia
  • +1 more
Aug 16, 2022

NSCLC Stage I, NSCLC Stage II Trial in Worldwide (Stereotactic Body Radiotherapy (SBRT))

Unknown status
  • Non-small Cell Lung Cancer Stage I
  • Non-small Cell Lung Cancer Stage II
  • Stereotactic Body Radiotherapy (SBRT)
  • Brussels, Belgium
  • +5 more
Jan 30, 2020

Lung Adenocarcinoma, Lymph Node Metastasis Trial in Shanghai (Selective Lymph Node Dissection)

Recruiting
  • Lung Adenocarcinoma
  • Lymph Node Metastasis
  • Selective Lymph Node Dissection
  • Shanghai, Please Select, China
    Chaoqiang Deng
Sep 4, 2023

NSCLC Trial in Jacksonville (Peripherally located lung tumor, Centrally located lung tumor)

Completed
  • Non-Small Cell Lung Cancer
  • Peripherally located lung tumor
  • Centrally located lung tumor
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
Mar 23, 2022

NSCLC, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer Trial in Boston (AGuIX, Radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Non Small Cell Lung Cancer Trial in Hines, Maywood (Group 1: Peripherally Located Tumors, Group 2: Peripherally Located Chest

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Group 1: Peripherally Located Tumors
  • +2 more
  • Hines, Illinois
  • +1 more
May 20, 2020

Lung Cancer Trial in Canada, United States (SBRT 40.0 Gy, SBRT 42.5 Gy, SBRT 45.0 Gy)

Completed
Has Results
  • Lung Cancer
  • SBRT 40.0 Gy
  • +8 more
  • Peoria, Arizona
  • +57 more
May 23, 2022

Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

Not yet recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • +5 more
  • Upfront resection
  • (no location specified)
Nov 9, 2022

NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body

Not yet recruiting
  • NSCLC
  • +3 more
  • Low Dose Radiotherapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Nov 11, 2022

NSCLC/Oligometastatic Cancer (Single Lung Lesion) Trial in Dublin (Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR))

Recruiting
  • NSCLC/Oligometastatic Cancer (Single Lung Lesion)
  • Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)
  • Dublin, Ireland
  • +1 more
Feb 11, 2022

Non Small Cell Lung Cancer Trial in Goyang-si (Brigatinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Lung Cancer, Lung Tumor Trial in Miami (Stereotactic Adaptive Ablative Radiotherapy at 50 Gy (Gray), Stereotactic Adaptive

Recruiting
  • Lung Cancer
  • Lung Tumor
  • Stereotactic Adaptive Ablative Radiotherapy at 50 Gy (Gray)
  • Stereotactic Adaptive Ablative Radiotherapy at 60 Gy (Gray)
  • Miami, Florida
    Miami Cancer Institute
May 24, 2022

Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally

Completed
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
  • Terni, TR, Italy
    Radiotherapy Oncology Centre "S.Maria" Hospital
Mar 22, 2022

Hepatocellular Carcinoma, Narrow Margin, Adjuvant Stereotactic Body Radiotherapy Trial in Hangzhou (stereotactic body radiation

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • stereotactic body radiation therapy
  • regular follow-up
  • Hangzhou, Zhejiang, China
    the second affiliated hospital of Zhejiang University
Nov 3, 2022

Arm Spasticity Trial in Worldwide (Botulinum toxin type A)

Terminated
Has Results
  • Arm Spasticity
  • Botulinum toxin type A
  • Aalborg, Denmark
  • +22 more
Sep 15, 2022

NSCLC Trial in Worldwide (Tepotinib, Osimertinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Yuma, Arizona
  • +178 more
Dec 19, 2022

Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases Trial in Amsterdam, Leiden (Cardiac condition measurements)

Recruiting
  • Lung Cancer Stage I
  • +2 more
  • Cardiac condition measurements
  • Amsterdam, Netherlands
  • +2 more
Jul 9, 2021

Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

Recruiting
  • Carcinoma
  • La Jolla, California
  • +95 more
Feb 1, 2023

NSCLC (NSCLC) Trial in Chongqing (Almonertinib, Stereotactic Radiotherapy(SRT) or Stereotactic Radiosurgery(SRS) or Whole-Brain

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Almonertinib
  • Stereotactic Radiotherapy(SRT) or Stereotactic Radiosurgery(SRS) or Whole-Brain Radiotherapy(WBRT)
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
May 31, 2021